Healthcare Provider Resources
The clinical practice and management of hepatitis C infection is changing quickly and dramatically. NYC health care providers are encouraged to become familiar with the new hepatitis C screening and testing recommendations and to have patients with chronic hepatitis C infection evaluated for one of the latest, and potentially curative, antiviral treatment regimens. Get more information about:
Latest updates from the NYC Department of Health and Mental Hygiene
- New, more effective and better tolerated treatments are now available that can cure hepatitis C.
- Order a hepatitis C antibody test for all patients at risk and everyone born between 1945 and 1965; positive hepatitis C antibody results should be followed with a test for viral RNA to assess current infection status.
- For patients infected with hepatitis C,
- Educate and counsel about abstaining from alcohol and offer appropriate vaccinations;
- Assess liver function and stage of liver disease;
- Consider starting one of the new antiviral treatment options;
- If you cannot provide treatment, refer to a provider who manages hepatitis C;
- Educate and counsel to prevent hepatitis C transmission.
- Hepatitis C in New York City: State of the Epidemic and Action Plan
The New York City Department of Health and Mental Hygiene, in collaboration with external stakeholders, has promulgated a plan to control hepatitis C with enhanced testing, linkage to care and treatment with emerging, more effective, and better tolerated antiviral treatment regimens. (September 2013)
- The New York City Hepatitis C Task Force is a coalition of providers, researchers, community-based organizations and advocates committed to addressing HCV-related issues in New York City.
Report suspected cases of acute hepatitis C
Because there is no laboratory test that distinguishes acute from chronic hepatitis C, we rely on clinicians to report new cases of suspected or confirmed acute hepatitis C. Learn more about reporting hepatitis C (and other notifiable diseases) to DOHMH here.
- Please report if:
- Patient tested negative for hepatitis C in the past 12 months and now tests positive.
- Patient with discrete onset of signs and symptoms (dark urine, light stool, fatigue, jaundice, fever, loss of appetite, diarrhea, nausea, vomiting, joint pain and/or abdominal pain) AND has elevated liver enzymes that, in the provider’s opinion, may indicate acute hepatitis C infection.
- You suspect a cluster of three or more persons with hepatitis C.
Do you have questions about which hepatitis serological test results are reportable to the Health Department? Refer to the Summary of Viral Hepatitis Lab Tests (April 2012).
Resources for Management and Treatment
Hepatitis C management and treatment standards are changing rapidly. All primary care providers, infectious disease specialists and gastroenterologists should become familiar with them.
On-Line Clinical Learning Opportunities
- University of Washington School of Medicine and International Antiviral Association (USA):
Hepatitis C On-Line Course (CME available)
CDC-funded site geared toward primary care providers. Video lectures and slide sets covering topics ranging from screening and testing through treatment of hepatitis C and its complications.
- Clinical Care Options – Section on HCV (CME available)
Video lectures and self-paced learning modules, including summaries from major hepatology conferences. Portal to Clinical Care Options’ decision support tools and continuing education resources in hepatitis, HIV, oncology, rheumatology, urology and transplantation.
- American Association for the Study of Liver Diseases (AASLD)
LiverLearning® -- Topic: Hepatitis C (CME available)
Official eLearning Portal of AASLD. Large repository of webcasts, podcasts, courses and abstracts.
Ancillary Information About Antiviral Medications for Hepatitis C
- Treatment Action Group (TAG)
Pipeline Report. Learn about the status of direct-acting agents and multi-drug regimens currently undergoing evaluation in clinical trials.
- Clinical Trials. Simple-to-navigate site that links providers and patients to clinical trials near to where they live.
Screening for and Addressing Behavioral Health Problems
- Screening, Brief Intervention and Referral to Treatment (SBIRT) – an evidence-based practice model to identify and manage patients at-risk from alcohol and substance use. Reimbursable by Medicaid, Medicare, and commercial insurers.
- NYC Department of Health and Mental Hygiene’s Bureau of Alcohol and Drug Use Prevention, Care and Treatment offers:
- SBIRT trainings ranging from 2.5 – 12 hours. Learn more
- Workflow analysis, integration on electronic health records, and billing, coding and reimbursement training. For more information, contact John McAteer, LCSW-R at firstname.lastname@example.org, (347) 396-7031 or SBIRTsupport@health.nyc.gov.
- Oregon’s SBIRT program is geared especially for use in primary care settings and includes useful tools and a variety of ready-to-use questionnaires. Learn more
- Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment (PREP-C). Interactive, on-line tool to assess a patient’s readiness to begin hepatitis C treatment.
- NYS Office of Alcoholism and Substance Abuse Services (OASAS)
Addictions Medicine Education Series. In-depth, on-line training for clinicians and credentialed alcoholism and substance abuse counselors and prevention experts.
- CoverMyMeds. Helps physicians and pharmacists complete Prior Authorization and other insurance coverage determination forms for any drug and almost all drug plans.
- Partnership for Prescription Assistance. For qualifying patients without prescription drug coverage, a single point of access to more than 475 public and private medication assistance programs, including nearly 200 offered by biopharmaceutical companies.
- NeedyMeds. Directs and helps people apply to medication assistance programs so they can afford their medications and health care.
- NYCRx. Improves access to affordable medications for medically underserved communities. Free Discount Prescription Card and list of partnering health centers with drug discount programs.